Ovid Therapeutics Inc. Debt Securities, Available-for-sale, Noncurrent
Ovid Therapeutics Inc. (OVID) had Debt Securities, Available-for-sale, Noncurrent of $52.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale, Noncurrent $52.55M.
- 2026-03-31: Debt Securities, Available-for-sale, Noncurrent $10.08M.
- 2025-12-31: Debt Securities, Available-for-sale, Noncurrent $20.81M.
- 2024-12-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2026-06-30 | $52.55M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $10.08M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $20.81M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |